Highlights
A collection of news and information related to Bristol Myers Squibb Company published by this site and its partners.
Displaying items 1-12 of 61
» View wsbtradio.com items only
1
2
3
4
5
6
•
Next >
-
UK scientists win funding for new kind of anticoagulant drug
ReutersLONDON, June 17 (Reuters) - British scientists have won early financial backing for a new kind of anticoagulant drug they believe may prevent dangerous blood clots without causing bleeding - a previously unachievable goal. Index Ventures, working with...Tags: Xarelto (drug), University of Cambridge, Johnson & Johnson Inc., Science and Technology, GlaxoSmithKline PLC
-
Drugmakers to cooperate in safety review of diabetes drugs
ReutersNEW YORK (Reuters) - Global drugmakers said on Wednesday they would cooperate with an independent review to address concerns of a potential link between widely used diabetes medicines and pancreatic cancer and other safety problems. The American Diabetes...Tags: Januvia (drug), National Institutes of Health, Diabetes, Pancreatic Cancer, Chemical Industry
-
UPDATE 1-Former Bristol-Myers executive admits to insider trading
Reuters* Robert Ramnarine pleads guilty to securities fraud * Defendant accused of buying options in takeover targets By Jonathan Stempel June 10 (Reuters) - A former Bristol-Myers Squibb Co finance executive on Monday pleaded guilty to an insider trading...Tags: Securities, Science and Technology, Amylin Pharmaceuticals Incorporated, Justice System, Gilead Sciences Inc.
-
U.S. RESEARCH ROUNDUP: Visa, Moody's, Facebook, BNY Mellon
ReutersJune 10 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S. companies including 3M and Facebook on Monday. HIGHLIGHTS * BNY Mellon : Raymond James raises price target to $33 from $31 * Western Union Co :...Tags: Titan International Incorporated, Thor Industries Incorporated, Illumina, Inc., Intel Corp., Weyerhaeuser Company
-
Sanofi avanza en el mercado de la diabetes ante dura competencia
ReutersPor Elena Berton FRANCFORT, 7 jun (Reuters) - En una barrio residencial de Fráncfort, Alemania, una planta de última generación produce diariamente hasta 1 millón de bolígrafos de insulina en el marco de una iniciativa de la farmacéutica francesa...Tags: Lantus (drug), Diabetes, Lilly Eli & Co, AstraZeneca Plc
-
FDA grants priority review status to Gilead's hepatitis C drug
ReutersJune 7 (Reuters) - Biotechnology company Gilead Sciences Inc said the U.S. Food and Drug Administration (FDA) granted priority review to its experimental hepatitis C drug sofosbuvir. The FDA grants priority reviews to medicines that are considered...Tags: Food and Drug Administration, Science and Technology, Biotechnology, Biotechnology Industry, Gilead Sciences Inc.
-
U.S. RESEARCH ROUNDUP: Abbott, Ciena, Visa, Bristol, Intel
ReutersJune 7 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S. companies, including J&J, Microsoft and Intel, on Friday. HIGHLIGHTS * U.S. healthcare: Jefferies cuts targets on Bristol-Myers Squibb, others...Tags: Titan International Incorporated, Intel Corp., Goldman Sachs Group, Inc., Northwest Pipe Company, Weight
-
Sanofi steps up diabetes drive as rivals raise the stakes
Reuters* French drugmaker banking on improved version of Lantus * Investing in smart technology to bolster diabetes business * Novo Nordisk setback an opportunity in competitive market * Key data on new Sanofi products at ADA meeting this month By Elena...Tags: Marketing, Diabetes, Lilly Eli & Co, Research and Development, Apple iPhone
-
U.S. RESEARCH ROUNDUP: Intel, Google, Bristol, Halliburton, Akamai
ReutersJune 3 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S. companies, including CME and TripAdvisor, on Monday. HIGHLIGHTS * Google Inc : Cantor Fitzgerald raises price target to $1030 from $900 *...Tags: Golar LNG Limited, Best Buy Co., Inc., Charles Schwab, Intel Corp., Halliburton Company
-
Merck KGaA's Erbitux beats Avastin in bowel cancer trial
ReutersFRANKFURT, June 1 (Reuters) - Merck KGaA's cancer drug Erbitux was shown to be more effective at prolonging the lives of bowel cancer patients than Roche's Avastin, Merck said. In a drug trial, the two drugs were each given in combination with Folfiri...Tags: Colon Cancer, Science and Technology, Chemotherapy, Oncology, Lilly Eli & Co
-
UK cost agency backs Astra, Bristol diabetes drug in some cases
ReutersLONDON, May 30 (Reuters) - Britain's healthcare cost watchdog NICE is recommending a new diabetes drug from Bristol-Myers Squibb and AstraZeneca in some circumstances, marking a change of tack following an earlier blanket rejection. The National...Tags: Pharmaceuticals, Drugs and Medicines, Diabetes, United Kingdom, Metformin (drug)
-
ANALYSIS-After tech success, Israel seeks life sciences growth
ReutersBy Tova Cohen and Steven Scheer HERZLIYA, Israel, June 6 (Reuters) - Inspired by its success in high-tech electronics and software, Israel is hoping to pull off the same trick in life sciences. The Mediterranean country already boasts the world's...Tags: Johnson & Johnson Inc., Science and Technology, Intel Corp., Multiple Sclerosis, Israel
Jun 16, 2013
|Story| Reuters
Jun 12, 2013
|Story| Reuters
Jun 10, 2013
|Story| Reuters
Jun 10, 2013
|Story| Reuters
Jun 7, 2013
|Story| Reuters
Jun 7, 2013
|Story| Reuters
Jun 7, 2013
|Story| Reuters
Jun 7, 2013
|Story| Reuters
Jun 3, 2013
|Story| Reuters
Jun 1, 2013
|Story| Reuters
May 29, 2013
|Story| Reuters
Jun 6, 2013
|Story| Reuters
Original site for Bristol Myers Squibb Company topic gallery.
